Cosciens Biopharma Inc.
13F holders, Q3 2024 (September 30)9holders
$3.71avg. 13F price*
At the end of Q3 2024, 9 institutions reported holding Cosciens Biopharma Inc. in their 13F filings. The largest holders were National Bank of Canada ($22K), Federation des caisses Desjardins du Quebec ($17K) and TD Waterhouse Canada Inc. ($14K).
- Company
- Cosciens Biopharma Inc.
- CUSIP
- 22112H101
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 10 | $62K |
| Exits | 0 | $0 |
Ownership 9 holders
| National Bank of Canada | 0.00% | New | 5,796 | $22K |
| Federation des caisses Desjardins du Quebec | 0.00% | New | 4,536 | $17K |
| TD Waterhouse Canada Inc. | 0.00% | New | 3,717 | $14K |
| Royal Bank of Canada | 0.00% | New | 2,527 | $9K |
| Osaic Holdings, Inc. | 0.00% | New | 50 | $185 |
| Tower Research Capital LLC (TRC) | 0.00% | New | 38 | $142 |
| Truvestments Capital LLC | 0.00% | New | 22 | $83 |
| Planning Capital Management Corp | 0.00% | New | 2 | $8 |
| Danske Bank A/S | 0.00% | New | 2 | $7 |
"% of holder's portfolio" is COSCIENS BIOPHARMA INC's weight in each manager's 13F, not the share of Cosciens Biopharma Inc. the manager owns.